References
Seliger C, Meier CR, Becker C, Jick SS, Bogdahn U, Hau P, Leitzmann MF. Statin use and risk of glioma: population-based case-control analysis. Eur J Epidemiol. 2016;31:947–51.
Greenland S, Senn SJ, Rothman KJ, Carlin JC, Poole C, Goodman SN, Altman DG. Statistical tests, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337–50.
Ferris JS, McCoy L, Neugut AI, Wrensch M, Lai R. HMG CoA reductase inhibitors, NSAIDs and risk of glioma. Int J Cancer. 2012;131(6):E1031–7.
Gaist D, Andersen L, Hallas J, Sorensen HT, Schroder HD, Friis S. Use of statins and risk of glioma: a nationwide case-control study in Denmark. Br J Cancer. 2013;108(3):715–20.
Greenland S, O’Rourke K. Meta-analysis, Ch. 33. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia: Lippincott; 2008. pp. 652–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Greenland, S. A serious misinterpretation of a consistent inverse association of statin use with glioma across 3 case-control studies. Eur J Epidemiol 32, 87–88 (2017). https://doi.org/10.1007/s10654-016-0205-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-016-0205-z